Navin Fluorine International reported a strong first quarter for FY27, with net profit rising 107.6% to ₹243.3 crore. Revenue increased 44.1% to ₹1,045.1 crore, supported by margin expansion to 34.2%.

Bodugum Akhilesh Reddy, 26, will not be able to play cricket until November 2033. Andy Mead/ISI Photos/Getty Images USA international cricketer Bodugum Akhilesh Reddy has been banned from all forms of ...

USA ‌international Akhilesh Reddy has ⁠been ⁠suspended for eight years after being found guilty of match-fixing, the International Cricket Council (ICC) says. Reddy was ⁠charged in November with ...

For someone whose office has a view of a carnival, Lonny Warner is decidedly unwhimsical. The CEO of Reddy Ice, the largest producer of packaged ice in North America, Warner is tall and broad in ...

Dr Reddy's Laboratories Ltd today reported its earnings for the first quarter of the financial year 2026-27. The pharmaceutical major posted a 68.7 per cent year-on-year (YoY) decline in consolidated ...

Good day, everyone and welcome to Quarter 1 FY '27 Earnings Call of Dr. Reddy's Laboratories Limited. We appreciate your continued interest in our company. I'm Aishwarya Sitharam, Head of Investor ...

Dr. Reddy's Laboratories (RDY) fell ~7% on Wednesday after the Indian drugmaker’s Q1 results for fiscal 2027 disappointed investors amid a new tariff threat from President Donald Trump targeting the ...

Dr. Reddy’s Laboratories Ltd. cut the first-year manufacturing target for its generic Ozempic drug as it paused commercial production until at least October after finding an unknown impurity in a key ...

Congo says Ebola outbreak spreads to northeastern Bas-Uele province Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the part of the drugmaker can take a toll. Case in point, Dr. Reddy’s share price ...

A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...

Nicholas Navin, Director, Advanced Spatial Genomics Core, Professor and Chair, Department of Systems Biology, Director, CPRIT Single Cell Genomics Center, Associate Professor at UT MD Anderson shared ...